Intro

This chapter explores recent initiatives in drug discovery, highlighting partnerships and funding aimed at treating fibrosis and sickle cell disease. It emphasizes the collaboration between Tessera Therapeutics and the Gates Foundation, as well as the impact of AI in enhancing research capabilities.

Play episode from 00:00

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app